Trade Summary

3 days ago, Pande Atul, serving as Dir at Immunovant, Inc. (IMVT), sold 1,500 shares at $34.02 per share, for a total transaction value of $51,030.00. Following this transaction, Pande Atul now holds 116,731 shares of IMVT.

This sale represents a 1.27% decrease in Pande Atul's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 16, 2026 at 4:03 PM ET, 1 day after the trade was made.

Immunovant, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.